Case Study: Major Pharma Company achieves over 90% remote completion and significant cost savings with Clario BYOD eCOA solution

Major pharma company eases data collection and maintains patient participation during a 2 1⁄2 year dermatitis study

Major Pharma Company needed a low-touch data capture solution for a 2½-year atopic dermatitis observational registry of 600 patients across ten countries, incorporating multiple validated instruments with quarterly remote and on-site assessments. Clario was engaged to provide a BYOD eCOA/Post‑Approval platform to collect study data without influencing patient behavior.

Clario delivered a native iOS/Android app, provisioned devices for about 20% of participants, and supplied site tablets, plus built-in reminders, guidance messaging, tailored training and a study portal for monitoring. The BYOD approach improved patient experience, cut costs versus a fully provisioned model, achieved over 90% completion rates for remote capture, and prompted Major Pharma Company to extend the study by another 2½ years.